Peter Herrick has represented clients in complex and challenging transactions and antitrust litigation for nearly 20 years. Peter has tried six merger litigations to final decisions, both for and against the government, including groundbreaking cases on behalf of the Federal Trade Commission. In addition to representing clients on mergers and acquisitions before the FTC, Department of Justice, and other antitrust regulators, Peter leads high stakes antitrust litigation for clients in federal court. Clients trust Peter’s strategic approach to both transactions and disputes, value his clear judgment, and depend on his credibility both in court and before the antitrust agencies.
Prior to returning to private practice, Peter was Senior Trial Counsel in the FTC’s Bureau of Competition. In that role, Peter co-led the FTC's 18-day trial and victory in FTC et al. v. St. Luke's Health System, Inc. et al., the FTC’s first successfully litigated merger challenge of a hospital system’s acquisition of a physician group. While in the FTC’s Mergers IV Division, he was a key trial team member in the FTC's successful merger challenges in FTC v. Phoebe Putney Health System and FTC v. OSF Health System. While at the FTC, Peter received the Janet D. Steiger Award three times for his contributions to key litigations.
Additionally, Peter acted as a lead staff attorney in FTC merger investigations, across a range of industries, including Visant Corp./American Achievement Corp., Capella Healthcare/St. Joseph's Mercy Health System, Geisinger Health System/ Community Medical Center, Community Health System, Inc./Moses Taylor Health Care System, and Grifols, S.A./Talecris Biotherapeutics Holdings Corp.
Peter speaks and writes frequently on antitrust issues, including recently at conferences for the American Health Lawyers’ Association and the New York State Bar Association, and in publications for the American Bar Association and Competition Policy International.